INTERNATIONAL TRADE COMMISSION ISSUES NOTICE: CERTAIN DRUG PRODUCTS CONTAINING C-TYPE NATRIURETIC PEPTIDE VARIANTS AND COMPONENTS THEREOF; NOTICE OF INSTITUTION OF INVESTIGATION

WASHINGTON, May 8 -- International Trade Commission has issued a notice called: Certain Drug Products Containing C-Type Natriuretic Peptide Variants and Components Thereof; Notice of Institution of Investigation.

The notice was published in the Federal Register on May 8 by Susan Orndoff, Supervisory Attorney.

Summary: Notice is hereby given that a complaint was filed with the U.S. International Trade Commission on April 2, 2025, under section 337 of the Tariff Act of 1930, as amended, on behalf of BioMarin Pharmaceutical Inc. of Novato, California. The complaint alleges violations of section 337 based upon the importation into the United States, the sale for importation, and the sale within the United States after importation of certain d...